Lung Cancer Trial, Recruiting NCT06628102 Sponsor: British Columbia Cancer Agency Condition: Lung Cancer
Back to Lung Cancer

Lung Cancer Trial, Recruiting

NCT06628102
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People aged between 50 and 80 years old
  • People who are able to give informed consent to participate
  • People whose chest CT scan has shown a nodule (a small growth or spot) measuring 6mm or larger
  • People who do not have any other type of cancer (apart from lung cancer, for those in group 1)
  • People who are able to avoid smoking tobacco for 24 hours before the breath test

Who may not be able to join:

  • People who are too unwell to provide a breath sample
  • People who have smoked within the last 24 hours before the test
  • People who are pregnant
  • People who have been diagnosed with a respiratory (breathing-related) infection in the last 3 months
  • People who are not willing to give consent to take part in the study

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 13 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Renelle L Myers, MD, VCH, UBC

Phone: 6046758096

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
British Columbia Cancer Agency
Registry
ClinicalTrials.gov
Start date
4 August 2023
Est. completion
31 December 2028

Where this trial is recruiting

🇨🇦 Canada

Primary endpoints

Develop the framework to assess the lung cancer risk of Incidental Pulmonary Nodule patients

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 13 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov